Neema Jamshidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Neema Jamshidi has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Aarash Bordbar
Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093-0412, USA
4 shared publications- Bernhard O. Palsson
Department of Bioengineering, University of California San Diego
4 shared publications - Michael D. Kuo
Affiliation Department of Radiology, The University of Hong Kong, Hong Kong, China
4 shared publications - Berfin Seyran
Department of Molecular Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, California, USA; Broad Center for Regenerative Medicine, University of California, Los Angeles, Los Angeles, California, USA
2 shared publications Bernhard Ø. Palsson
1] Department of Bioengineering, 9500 Gilman Drive, Mail Code 0412, La Jolla, CA 92093-0412 [2] Institute of Engineering and Medicine, 9500 Gilman Drive, Mail Code 0412, La Jolla, CA 92093-0412 [3] University of California, San Diego, 9500 Gilman Drive, Mail Code 0412, La Jolla, CA 92093-0412
2 shared publicationsJayasuriya Senthilvelan
Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, USA
2 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Aryl hydrocarbon receptor in the kidney regulates metabolic cross-talk with the liver and gut microbiome
Aryl hydrocarbon receptor (AHR) is central to inter-organ and inter-organismal crosstalk along the gut microbiome-liver-kidney axis. Studies in the kidney indicate this is due its regulation of transporter-mediated "remote sensing and signaling" via small molecules derived from the gut microbiome. These include gut microbiome-derived uremic toxins (e.g., indoxyl sulfate) associated with chronic kidney disease (CKD), which are transported by OAT1 and other SLC transporters. However, how kidney AHR regulates gut microbiome-liver-kidney crosstalk is largely unexplored. Here, we applied formal multi-organ metabolic reconstruction to multiomics data from the kidney of AHR knockout mouse and contextualized it with systemic metabolic changes. Consistent with the Remote Sensing and Signaling Theory, the explicit and quantitative multi-organ host and microbe network reconstruction revealed that kidney AHR regulates correlated sets of biochemical reactions at the organ, cellular, and organellar levels. In the absence of kidney AHR, there is up-regulation of polyamine related metabolism and down regulation of pathways involving organic acids (oxalate), thiamine, and amino-, methyl-, and phospho-transferases. Importantly, these AHR-dependent changes in correlated reaction sets occur not only in the kidney but also in the liver and microbiome. The normal inter-organ and inter-organismal (host-microbe) communication via these biochemical pathways between the kidney and other organs is disrupted when AHR function is lost. Thus, the incorporation of tissue and plasma metabolomics with kidney and liver transcriptomics in a biologically coherent framework provides a novel view into the metabolic relationships across the gut microbiome-liver-kidney axis. Through a concordance–discordance assessment of the transcriptome and metabolome, we were able to identify potential metabolic regulatory hubs dependent upon kidney AHR, a uremic toxin sensor and drug target. This included observed up-regulation of urea cycle enzymes with down-regulation of more distant enzymes (that are not directly involved with nitrogen handling). The results show how AHR-dependent remote sensing and signaling can involve interactions via biochemical reaction sub-networks between distinct organellar compartments of the communicating kidney and liver.
- 24 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessAryl hydrocarbon receptor in the kidney regulates metabolic cross-talk with the liver and gut microbiome
Aryl hydrocarbon receptor (AHR) is central to inter-organ and inter-organismal crosstalk along the gut microbiome-liver-kidney axis. Studies in the kidney indicate this is due its regulation of transporter-mediated "remote sensing and signaling" via small molecules derived from the gut microbiome. These include gut microbiome-derived uremic toxins (e.g., indoxyl sulfate) associated with chronic kidney disease (CKD), which are transported by OAT1 and other SLC transporters. However, how kidney AHR regulates gut microbiome-liver-kidney crosstalk is largely unexplored. Here, we applied formal multi-organ metabolic reconstruction to multiomics data from the kidney of AHR knockout mouse and contextualized it with systemic metabolic changes. Consistent with the Remote Sensing and Signaling Theory, the explicit and quantitative multi-organ host and microbe network reconstruction revealed that kidney AHR regulates correlated sets of biochemical reactions at the organ, cellular, and organellar levels. In the absence of kidney AHR, there is up-regulation of polyamine related metabolism and down regulation of pathways involving organic acids (oxalate), thiamine, and amino-, methyl-, and phospho-transferases. Importantly, these AHR-dependent changes in correlated reaction sets occur not only in the kidney but also in the liver and microbiome. The normal inter-organ and inter-organismal (host-microbe) communication via these biochemical pathways between the kidney and other organs is disrupted when AHR function is lost. Thus, the incorporation of tissue and plasma metabolomics with kidney and liver transcriptomics in a biologically coherent framework provides a novel view into the metabolic relationships across the gut microbiome-liver-kidney axis. Through a concordance–discordance assessment of the transcriptome and metabolome, we were able to identify potential metabolic regulatory hubs dependent upon kidney AHR, a uremic toxin sensor and drug target. This included observed up-regulation of urea cycle enzymes with down-regulation of more distant enzymes (that are not directly involved with nitrogen handling). The results show how AHR-dependent remote sensing and signaling can involve interactions via biochemical reaction sub-networks between distinct organellar compartments of the communicating kidney and liver.
- Open Access
The loss of peroxiredoxin 2 in mice disrupts the biochemical aging phenotype in erythrocytes
- Open Access
- 23 September 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202402743
Dysfunctional β-cell longevity in diabetes relies on energy conservation and positive epistasis
Long-lived PFKFB3-expressing β-cells are dysfunctional partly because of prevailing glycolysis that compromises metabolic coupling of insulin secretion. Their accumulation in type 2 diabetes (T2D) appears to be related to the loss of apoptotic competency of cell fitness competition that maintains islet function by favoring constant selection of healthy “winner” cells. To investigate how PFKFB3 can disguise the competitive traits of dysfunctional “loser” β-cells, we analyzed the overlap between human β-cells with bona fide “loser signature” across diabetes pathologies using the HPAP scRNA-seq and spatial transcriptomics of PFKFB3-positive β-cells from nPOD T2D pancreata. The overlapping transcriptional profile of “loser” β-cells was represented by down-regulated ribosomal biosynthesis and genes encoding for mitochondrial respiration. PFKFB3-positive “loser” β-cells had the reduced expression of HLA class I and II genes. Gene–gene interaction analysis revealed that PFKFB3rs1983890can interact with the anti-apoptotic geneMAIP1implicating positive epistasis as a mechanism for prolonged survival of “loser” β-cells in T2D. Inhibition of PFKFB3 resulted in the clearance of dysfunctional “loser” β-cells leading to restored glucose tolerance in the mouse model of T2D.
- 23 September 2024
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 7 (12) , e202402743
Open AccessDysfunctional β-cell longevity in diabetes relies on energy conservation and positive epistasis
Long-lived PFKFB3-expressing β-cells are dysfunctional partly because of prevailing glycolysis that compromises metabolic coupling of insulin secretion. Their accumulation in type 2 diabetes (T2D) appears to be related to the loss of apoptotic competency of cell fitness competition that maintains islet function by favoring constant selection of healthy “winner” cells. To investigate how PFKFB3 can disguise the competitive traits of dysfunctional “loser” β-cells, we analyzed the overlap between human β-cells with bona fide “loser signature” across diabetes pathologies using the HPAP scRNA-seq and spatial transcriptomics of PFKFB3-positive β-cells from nPOD T2D pancreata. The overlapping transcriptional profile of “loser” β-cells was represented by down-regulated ribosomal biosynthesis and genes encoding for mitochondrial respiration. PFKFB3-positive “loser” β-cells had the reduced expression of HLA class I and II genes. Gene–gene interaction analysis revealed that PFKFB3rs1983890can interact with the anti-apoptotic geneMAIP1implicating positive epistasis as a mechanism for prolonged survival of “loser” β-cells in T2D. Inhibition of PFKFB3 resulted in the clearance of dysfunctional “loser” β-cells leading to restored glucose tolerance in the mouse model of T2D.
- Open Access
Dysfunctional β-cell longevity in diabetes relies on energy conservation and positive epistasis
Long-lived PFKFB3 expressing β-cells are dysfunctional cells because of prevailing glycolysis that compromises metabolic coupling of insulin secretion. Their accumulation in type-2 diabetes (T2D) appears to be related to the loss of apoptotic competency of cell fitness competition (CFC) that maintains tissue function by favoring constant selection of healthy “winner” cells. To investigate how PFKFB3 can disguise the competitive traits of dysfunctional “loser” β-cells, we analyzed the overlap between human β-cells with bona-fide “loser signature” across diabetes pathologies utilizing the HPAP scRNA-seq and spatial transcriptomics of PFKFB3 positive β-cells from nPOD T2D pancreata. The overlapping transcriptional profile of “loser” β-cells was represented by downregulated ribosomal biogenesis- and genes encoding for mitochondrial respiration. PFKFB3 positive “loser” β-cells had reduced expression of HLA Class I and II genes. Gene-gene interaction analysis revealed that PFKFB3 rs1983890 can interact with anti-apoptotic gene MAIP1 implicating positive epistasis as a mechanism for prolonged survival of “loser” β-cells in T2D. Inhibition of PFKFB3 resulted in the clearance of dysfunctional “loser” β-cells leading to restored glucose tolerance in mouse model of T2D.
Open AccessDysfunctional β-cell longevity in diabetes relies on energy conservation and positive epistasis
Long-lived PFKFB3 expressing β-cells are dysfunctional cells because of prevailing glycolysis that compromises metabolic coupling of insulin secretion. Their accumulation in type-2 diabetes (T2D) appears to be related to the loss of apoptotic competency of cell fitness competition (CFC) that maintains tissue function by favoring constant selection of healthy “winner” cells. To investigate how PFKFB3 can disguise the competitive traits of dysfunctional “loser” β-cells, we analyzed the overlap between human β-cells with bona-fide “loser signature” across diabetes pathologies utilizing the HPAP scRNA-seq and spatial transcriptomics of PFKFB3 positive β-cells from nPOD T2D pancreata. The overlapping transcriptional profile of “loser” β-cells was represented by downregulated ribosomal biogenesis- and genes encoding for mitochondrial respiration. PFKFB3 positive “loser” β-cells had reduced expression of HLA Class I and II genes. Gene-gene interaction analysis revealed that PFKFB3 rs1983890 can interact with anti-apoptotic gene MAIP1 implicating positive epistasis as a mechanism for prolonged survival of “loser” β-cells in T2D. Inhibition of PFKFB3 resulted in the clearance of dysfunctional “loser” β-cells leading to restored glucose tolerance in mouse model of T2D.
- Open Access
- 8 August 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (8) , 929
Multi-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is a multifaceted disease that progresses through multiple phases; it involves metabolic as well as structural changes. These alterations can be measured directly or indirectly through blood, non-invasive imaging, and/or tissue analyses. While some studies have evaluated the correlations between two sets of measurements (e.g., histopathology with cross-sectional imaging or blood biomarkers), the interrelationships, if any, among histopathology, clinical blood profiles, cross-sectional imaging, and metabolomics in a pediatric cohort remain unknown. We created a multiparametric clinical MRI–histopathologic NMR network map of pediatric NAFLD through multimodal correlation networks, in order to gain insight into how these different sets of measurements are related. We found that leptin and other blood markers were correlated with many other measurements; however, upon filtering out the blood biomarkers, the network was decomposed into three independent hubs centered around histopathological features, each with associated MRI and plasma metabolites. These multi-modality maps could serve as a framework for characterizing disease status and progression and could potentially guide medical interventions.
- 8 August 2023
- Published by MDPI AG in Metabolites
- Vol. 13 (8) , 929
Open AccessMulti-Modality, Multi-Dimensional Characterization of Pediatric Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is a multifaceted disease that progresses through multiple phases; it involves metabolic as well as structural changes. These alterations can be measured directly or indirectly through blood, non-invasive imaging, and/or tissue analyses. While some studies have evaluated the correlations between two sets of measurements (e.g., histopathology with cross-sectional imaging or blood biomarkers), the interrelationships, if any, among histopathology, clinical blood profiles, cross-sectional imaging, and metabolomics in a pediatric cohort remain unknown. We created a multiparametric clinical MRI–histopathologic NMR network map of pediatric NAFLD through multimodal correlation networks, in order to gain insight into how these different sets of measurements are related. We found that leptin and other blood markers were correlated with many other measurements; however, upon filtering out the blood biomarkers, the network was decomposed into three independent hubs centered around histopathological features, each with associated MRI and plasma metabolites. These multi-modality maps could serve as a framework for characterizing disease status and progression and could potentially guide medical interventions.
- Open Access
- 22 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 780
Loss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice
High uric acid is associated with gout, hypertension, metabolic syndrome, cardiovascular disease, and kidney disease. URAT1 (SLC22A12), originally discovered in mice as Rst, is generally considered a very selective uric acid transporter compared to other closely-related kidney uric acid transporters such as OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8). While the role of URAT1 in regulating human uric acid is well-established, in recent studies the gene has been linked to redox regulation in flies as well as progression of renal cell carcinoma. We have now identified over twenty metabolites in the Urat1 knockout that are generally distinct from metabolites accumulating in the Oat1 and Oat3 knockout mice, with distinct molecular properties as revealed by chemoinformatics and machine learning analysis. These metabolites are involved in seemingly disparate aspects of cellular metabolism, including pyrimidine, fatty acid, and amino acid metabolism. However, through integrative systems metabolic analysis of the transcriptomic and metabolomic data using a human metabolic reconstruction to build metabolic genome-scale models (GEMs), the cellular response to loss of Urat1/Rst revealed compensatory processes related to reactive oxygen species handling and maintaining redox state balances via Vitamin C metabolism and cofactor charging reactions. These observations are consistent with the increasingly appreciated role of the antioxidant properties of uric acid. Collectively, the results highlight the role of Urat1/Rst as a transporter strongly tied to maintaining redox homeostasis, with implications for metabolic side effects from drugs that block its function.
- 22 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (3) , 780
Open AccessLoss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice
High uric acid is associated with gout, hypertension, metabolic syndrome, cardiovascular disease, and kidney disease. URAT1 (SLC22A12), originally discovered in mice as Rst, is generally considered a very selective uric acid transporter compared to other closely-related kidney uric acid transporters such as OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8). While the role of URAT1 in regulating human uric acid is well-established, in recent studies the gene has been linked to redox regulation in flies as well as progression of renal cell carcinoma. We have now identified over twenty metabolites in the Urat1 knockout that are generally distinct from metabolites accumulating in the Oat1 and Oat3 knockout mice, with distinct molecular properties as revealed by chemoinformatics and machine learning analysis. These metabolites are involved in seemingly disparate aspects of cellular metabolism, including pyrimidine, fatty acid, and amino acid metabolism. However, through integrative systems metabolic analysis of the transcriptomic and metabolomic data using a human metabolic reconstruction to build metabolic genome-scale models (GEMs), the cellular response to loss of Urat1/Rst revealed compensatory processes related to reactive oxygen species handling and maintaining redox state balances via Vitamin C metabolism and cofactor charging reactions. These observations are consistent with the increasingly appreciated role of the antioxidant properties of uric acid. Collectively, the results highlight the role of Urat1/Rst as a transporter strongly tied to maintaining redox homeostasis, with implications for metabolic side effects from drugs that block its function.
- Open Access
- 27 February 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-12
Construction of a radiogenomic association map of pancreatic ductal adenocarcinoma
Background: Pancreatic adenocarcinoma (PDAC) persists as a malignancy with high morbidity and mortality that can benefit from new means to characterize and detect these tumors, such as radiogenomics. In order to address this gap in the literature, constructed a transcriptomic-CT radiogenomic (RG) map for PDAC. Methods: In this Institutional Review Board approved study, a cohort of subjects (n = 50) with gene expression profile data paired with histopathologically confirmed resectable or borderline resectable PDAC were identified. Studies with pre-operative contrast–enhanced CT images were independently assessed for a set of 88 predefined imaging features. Microarray gene expression profiling was then carried out on the histopathologically confirmed pancreatic adenocarcinomas and gene networks were constructed using Weighted Gene Correlation Network Analysis (WCGNA) (n = 37). Data were analyzed with bioinformatics analyses, multivariate regression-based methods, and Kaplan-Meier survival analyses. Results: Survival analyses identified multiple features of interest that were significantly associated with overall survival, including Tumor Height (P = 0.014), Tumor Contour (P = 0.033), Tumor-stroma Interface (P = 0.014), and the Tumor Enhancement Ratio (P = 0.047). Gene networks for these imaging features were then constructed using WCGNA and further annotated according to the Gene Ontology (GO) annotation framework for a biologically coherent interpretation of the imaging trait-associated gene networks, ultimately resulting in a PDAC RG CT-transcriptome map composed of 3 stage-independent imaging traits enriched in metabolic processes, telomerase activity, and podosome assembly (P < 0.05). Conclusions: A CT-transcriptomic RG map for PDAC composed of semantic and quantitative traits with associated biology processes predictive of overall survival, was constructed, that serves as a reference for further mechanistic studies for non-invasive phenotyping of pancreatic tumors.
- 27 February 2023
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-12
Open AccessConstruction of a radiogenomic association map of pancreatic ductal adenocarcinoma
Background: Pancreatic adenocarcinoma (PDAC) persists as a malignancy with high morbidity and mortality that can benefit from new means to characterize and detect these tumors, such as radiogenomics. In order to address this gap in the literature, constructed a transcriptomic-CT radiogenomic (RG) map for PDAC. Methods: In this Institutional Review Board approved study, a cohort of subjects (n = 50) with gene expression profile data paired with histopathologically confirmed resectable or borderline resectable PDAC were identified. Studies with pre-operative contrast–enhanced CT images were independently assessed for a set of 88 predefined imaging features. Microarray gene expression profiling was then carried out on the histopathologically confirmed pancreatic adenocarcinomas and gene networks were constructed using Weighted Gene Correlation Network Analysis (WCGNA) (n = 37). Data were analyzed with bioinformatics analyses, multivariate regression-based methods, and Kaplan-Meier survival analyses. Results: Survival analyses identified multiple features of interest that were significantly associated with overall survival, including Tumor Height (P = 0.014), Tumor Contour (P = 0.033), Tumor-stroma Interface (P = 0.014), and the Tumor Enhancement Ratio (P = 0.047). Gene networks for these imaging features were then constructed using WCGNA and further annotated according to the Gene Ontology (GO) annotation framework for a biologically coherent interpretation of the imaging trait-associated gene networks, ultimately resulting in a PDAC RG CT-transcriptome map composed of 3 stage-independent imaging traits enriched in metabolic processes, telomerase activity, and podosome assembly (P < 0.05). Conclusions: A CT-transcriptomic RG map for PDAC composed of semantic and quantitative traits with associated biology processes predictive of overall survival, was constructed, that serves as a reference for further mechanistic studies for non-invasive phenotyping of pancreatic tumors.
- Open Access
- 31 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-22
Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions
In vitro and in vivo studies have established the organic anion transporters OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8) among the main multi-specific “drug” transporters. They also transport numerous endogenous metabolites, raising the possibility of drug-metabolite interactions (DMI). To help understand the role of these drug transporters on metabolism across scales ranging from organ systems to organelles, a formal multi-scale analysis was performed. Metabolic network reconstructions of the omics-alterations resulting from Oat1 and Oat3 gene knockouts revealed links between the microbiome and human metabolism including reactions involving small organic molecules such as dihydroxyacetone, alanine, xanthine, and p-cresol—key metabolites in independent pathways. Interestingly, pairwise organ-organ interactions were also disrupted in the two Oat knockouts, with altered liver, intestine, microbiome, and skin-related metabolism. Compared to older models focused on the “one transporter-one organ” concept, these more sophisticated reconstructions, combined with integration of a multi-microbial model and more comprehensive metabolomics data for the two transporters, provide a considerably more complex picture of how renal “drug” transporters regulate metabolism across the organelle (e.g. endoplasmic reticulum, Golgi, peroxisome), cellular, organ, inter-organ, and inter-organismal scales. The results suggest that drugs interacting with OAT1 and OAT3 can have far reaching consequences on metabolism in organs (e.g. skin) beyond the kidney. Consistent with the Remote Sensing and Signaling Theory (RSST), the analysis demonstrates how transporter-dependent metabolic signals mediate organ crosstalk (e.g., gut-liver-kidney) and inter-organismal communication (e.g., gut microbiome-host).
- 31 October 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-22
Open AccessDrug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions
In vitro and in vivo studies have established the organic anion transporters OAT1 (SLC22A6, NKT) and OAT3 (SLC22A8) among the main multi-specific “drug” transporters. They also transport numerous endogenous metabolites, raising the possibility of drug-metabolite interactions (DMI). To help understand the role of these drug transporters on metabolism across scales ranging from organ systems to organelles, a formal multi-scale analysis was performed. Metabolic network reconstructions of the omics-alterations resulting from Oat1 and Oat3 gene knockouts revealed links between the microbiome and human metabolism including reactions involving small organic molecules such as dihydroxyacetone, alanine, xanthine, and p-cresol—key metabolites in independent pathways. Interestingly, pairwise organ-organ interactions were also disrupted in the two Oat knockouts, with altered liver, intestine, microbiome, and skin-related metabolism. Compared to older models focused on the “one transporter-one organ” concept, these more sophisticated reconstructions, combined with integration of a multi-microbial model and more comprehensive metabolomics data for the two transporters, provide a considerably more complex picture of how renal “drug” transporters regulate metabolism across the organelle (e.g. endoplasmic reticulum, Golgi, peroxisome), cellular, organ, inter-organ, and inter-organismal scales. The results suggest that drugs interacting with OAT1 and OAT3 can have far reaching consequences on metabolism in organs (e.g. skin) beyond the kidney. Consistent with the Remote Sensing and Signaling Theory (RSST), the analysis demonstrates how transporter-dependent metabolic signals mediate organ crosstalk (e.g., gut-liver-kidney) and inter-organismal communication (e.g., gut microbiome-host).
- Open Access
- 22 September 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
A pipeline for automated deep learning liver segmentation (PADLLS) from contrast enhanced CT exams
Multiple studies have created state-of-the-art liver segmentation models using Deep Convolutional Neural Networks (DCNNs) such as the V-net and H-DenseUnet. Oversegmentation however continues to be a problem. We set forth to address these limitations by developing a an automated workflow that leverages the strengths of different DCNN architectures, resulting in a pipeline that enables fully automated liver segmentation. A Pipeline for Automated Deep Learning Liver Segmentation (PADLLS) was developed and implemented that cascades multiple DCNNs that were trained on more than 200 CT scans. First, a V-net is used to create a rough liver, spleen, and stomach mask. After stomach and spleen pixels are removed using their respective masks and ascites is removed using a morphological algorithm, the scan is passed to a H-DenseUnet to yield the final segmentation. The segmentation accuracy of the pipleline was compared to the H-DenseUnet and the V-net using the SLIVER07 and 3DIRCADb datasets as benchmarks. The PADLLS Dice score for the SLIVER07 dataset was calculated to be 0.957 ± 0.033 and was significantly better than the H-DenseUnet’s score of 0.927 ± 0.044 (p = 0.0219) and the V-net’s score of 0.872 ± 0.121 (p = 0.0067). The PADLLS Dice score for the 3DIRCADb dataset was 0.965 ± 0.016 and was significantly better than the H-DenseUnet’s score of 0.930 ± 0.041 (p = 0.0014) the V-net’s score of 0.874 ± 0.060 (p < 0.001). In conclusion, our pipeline (PADLLS) outperforms existing liver segmentation models, serves as a valuable tool for image-based analysis, and is freely available for download and use.
- 22 September 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessA pipeline for automated deep learning liver segmentation (PADLLS) from contrast enhanced CT exams
Multiple studies have created state-of-the-art liver segmentation models using Deep Convolutional Neural Networks (DCNNs) such as the V-net and H-DenseUnet. Oversegmentation however continues to be a problem. We set forth to address these limitations by developing a an automated workflow that leverages the strengths of different DCNN architectures, resulting in a pipeline that enables fully automated liver segmentation. A Pipeline for Automated Deep Learning Liver Segmentation (PADLLS) was developed and implemented that cascades multiple DCNNs that were trained on more than 200 CT scans. First, a V-net is used to create a rough liver, spleen, and stomach mask. After stomach and spleen pixels are removed using their respective masks and ascites is removed using a morphological algorithm, the scan is passed to a H-DenseUnet to yield the final segmentation. The segmentation accuracy of the pipleline was compared to the H-DenseUnet and the V-net using the SLIVER07 and 3DIRCADb datasets as benchmarks. The PADLLS Dice score for the SLIVER07 dataset was calculated to be 0.957 ± 0.033 and was significantly better than the H-DenseUnet’s score of 0.927 ± 0.044 (p = 0.0219) and the V-net’s score of 0.872 ± 0.121 (p = 0.0067). The PADLLS Dice score for the 3DIRCADb dataset was 0.965 ± 0.016 and was significantly better than the H-DenseUnet’s score of 0.930 ± 0.041 (p = 0.0014) the V-net’s score of 0.874 ± 0.060 (p < 0.001). In conclusion, our pipeline (PADLLS) outperforms existing liver segmentation models, serves as a valuable tool for image-based analysis, and is freely available for download and use.
- 1 May 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (3) , 260-263
Looking beyond the gunsight: A potential bailout technique for arterial and venous recanalization
The "gunsight approach" was initially described as the use of overlapping snares and through-and-through puncture of the portal vein and inferior vena cava for the creation of a transcaval portosystemic shunt. This technique can be adapted for the creation of an extra-anatomic channel between any 2 locations where snares can be deployed. We explain the technique, discuss finer technical points, and describe 2 cases where refractory vascular occlusions are crossed using this technique. The first case involves an extensively calcified femoral arterial chronic total occlusion where subintimal tracking past the occlusion is achieved, but luminal re-entry is hampered by dense calcific plaque refractory to multiple re-entry devices. The second case involves a chronic venous occlusion along the femoral vein with loss of in-line flow due to prior stenting. In both cases, the gunsight technique was successfully used as a bailout option after standard recanalization techniques were unsuccessful.
- 1 May 2022
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 28 (3) , 260-263
Looking beyond the gunsight: A potential bailout technique for arterial and venous recanalization
The "gunsight approach" was initially described as the use of overlapping snares and through-and-through puncture of the portal vein and inferior vena cava for the creation of a transcaval portosystemic shunt. This technique can be adapted for the creation of an extra-anatomic channel between any 2 locations where snares can be deployed. We explain the technique, discuss finer technical points, and describe 2 cases where refractory vascular occlusions are crossed using this technique. The first case involves an extensively calcified femoral arterial chronic total occlusion where subintimal tracking past the occlusion is achieved, but luminal re-entry is hampered by dense calcific plaque refractory to multiple re-entry devices. The second case involves a chronic venous occlusion along the femoral vein with loss of in-line flow due to prior stenting. In both cases, the gunsight technique was successfully used as a bailout option after standard recanalization techniques were unsuccessful.